70710-1931 : Maraviroc 300 mg Oral Tablet, Film Coated


NDC: 70710-1931
Labeler: Zydus Pharmaceuticals USA Inc.
Product Type: Human Prescription Drug
Drug Name:  Maraviroc
Dosage Form: Oral Tablet, Film Coated
Application #: ANDA217880
Rev. Date: 


NDC Package Codes:

  • 70710-1931-6: 60 TABLET, FILM COATED IN 1 BOTTLE (70710‑1931‑6)

Active Ingredients:

  • Maraviroc

Dosage Strength:

  • 300 mg

Pharmaceutical Classes:

  • CCR5 Co-receptor Antagonist [EPC]
  • Chemokine Co-receptor 5 Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 70710-1930 Maraviroc 150 mg Oral Tablet, Film Coated by Zydus Pharmaceuticals USA Inc.
  • 31722-579 Maraviroc 150 mg Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 31722-580 Maraviroc 300 mg Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 68554-3079 Maraviroc 150 mg Oral Tablet, Film Coated by Hetero Labs Limited
  • 68554-3080 Maraviroc 300 mg Oral Tablet, Film Coated by Hetero Labs Limited
  • 72319-024 Maraviroc 150 mg Oral Tablet, Film Coated by I3 Pharmaceuticals, LLC
  • 72319-025 Maraviroc 300 mg Oral Tablet, Film Coated by I3 Pharmaceuticals, LLC
  • 72865-231 Maraviroc 150 mg Oral Tablet, Film Coated by Xlcare Pharmaceuticals Inc.
  • 72865-232 Maraviroc 300 mg Oral Tablet, Film Coated by Xlcare Pharmaceuticals Inc.
  • 73141-024 Maraviroc 150 mg Oral Tablet, Film Coated by A2a Integrated Pharmaceuticals
  • 73141-025 Maraviroc 300 mg Oral Tablet, Film Coated by A2a Integrated Pharmaceuticals

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 70710-1931 QR Code

< Prev: 70710-1930Next: 70710-1937 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.